Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: parenteral chemotherapy
Sponsor: Warwick Medical School